Maynard Um
-
-
-
-
-
-
-
BioCardia announces public offering of up to 2.8 million shares and warrants
-
-
-
-
-
-
-
BioCardia's (BCDA) Phase 3 CardiAMP-HF Trial Shows Increased Survival, Decreased Cardiac Events, and Improved Quality of Life at Two Years
-
-
-
-
-
-
-
BioCardia (BCDA) Regains Full Compliance with Nasdaq Listing Requirements
-
-
-
-
-
-
-
BioCardia (BCDA) Receives US Patent on Morph DNA Multi-Directional Steerable Catheter Transseptal Application
341,965 total articles have been posted to this entity.
Click Here to Sign-Up for StreetInsider.com Premium to View All

